Facebook Facebook Share

APPGSet up in 2011, the All-Party Parliamentary Group (APPG) on Ovarian Cancer is made up of MPs and peers and meets several times during the year. Target Ovarian Cancer provides secretariat duties for the group. 

The purpose of the APPG is:

  • to provide a forum for MPs and Peers to discuss ovarian cancer related issues
  • to raise areas of concern with government or other policy makers
  • to raise the profile of ovarian cancer within parliament
  • to seek opportunities to help improve survival and quality of life for women with ovarian cancer

If you would like to join the APPG  mailing list or would like more information please contact appg@targetovariancancer.org.uk

The APPG’s work 2011-present 


  • 12 September 2018. The APPG held its Annual General Meeting. At the meeting the group agreed the forward programme for the next year and elected the group's officers. The results of the AGM are avaliable here
  • 8 May 2018. The APPG launched the report of the group’s first ever inquiry Diagnosing ovarian cancer sooner: what more can be done, to mark World Ovarian Cancer Day 2018. The report examines what more needs be done in the prevention, screening, awareness and diagnosis of ovarian cancer.
  • 14 March 2018. Teal Heroes Photo Opportunity, MPs showed their support for Ovarian Cancer Awareness Month by dressing as teal heroes to raise awareness of the symptoms of ovarian cancer. We were delighted that 14 MPs came to show their support. We had some really great conversations with each MP about how they can help us reach our goal of making sure women with ovarian cancer have the best chances of survival.
  • 20 February. The APPG held two oral evidence sessions as part of the group’s inquiry Diagnosing ovarian cancer sooner: what more can be done. The group heard from a range of witnesses, to take stock of progress to date in diagnosing ovarian cancer as well what new ideas and approaches could be adopted.


  • 15 November 2017. This meeting looked at ovarian cancer treatments and the current approval process as well as hearing about new treatments for ovarian cancer, Rucaparib and Niraparib
  • 12 September 2017. Annual General Meeting 2017.


  • 20 July 2016. Annual General Meeting 2016.
  • 2 March 2016. This meeting focused on Routes to Diagnosis data. Chris Carrigan of the National Cancer Intelligence Network presented data on how women are diagnosed with ovarian cancer, including the numbers of women diagnosed in A&E. Esther Matthews, described to the meeting her experience of being initially misdiagnosed, which meant that by the time she was finally diagnosed her cancer had reached stage IV.
  • 3 February 2016 A joint APPG meeting with the APPGs on Brain Tumours, Breast Cancer, Cancer, and Pancreatic Cancer on the Cancer Drugs Fund.


  • 4 November 2015. The group that looked access to cancer drugs across the UK.The meeting provided an overview of the approval process for new drugs and how this varies across the UK.
  • 10 June 2015. Annual General Meeting 2015.
  • 4 March 2015. The meeting covered the important issues of new treatments, clinical trials and genetic testing. This included access to trials for women with ovarian cancer and the importance of  BRCA testing for women with ovarian cancer.



  • 30 October 2013. The group heard about the evaluation of the Be Clear on Cancer pilots for ovarian cancer, and the priorities of the new National Cancer Director. The group also discussed what action could be taken to help women in the devolved nations gain access to Avastin.
  • 5 June 2013. The group discussed the drug Avastin, and its availability around the UK. Speakers included Dr Tim Perren, Consultant Oncologist who led the UK trials for Avastin.
  • 5 February 2013. The group discussed the future of the Be Clear on Cancer pilots, and the Medical Innovation Bill.


  • 30 October 2012. The group discussed ovarian cancer screening, and the forthcoming Be Clear on Cancer pilots for ovarian cancer and heard updates from the Gynaecological Cancer Research Centre and the Cancer Policy Team, DH.
  • 11 July 2012. Annual General Meeting 2012. 
  • 10 May 2012. The group looked at access to drugs. The group raised concerns over the supply of the drug Caelyx for women with advanced ovarian cancer and have written to the European Medicines Agency.
  • 7 February 2012. The group discussed the challenges and opportunities in ovarian cancer research. Speakers included NCIN Gynaecological Clinical Reference Group and the NCRI Gynae Cancer Clinical Studies Group


  • 29 November 2011. A delegated group of APPG members met with Paul Burstow MP, Minister for Care Services  to further discuss some of the points raised during the Westminster Hall Debate.
  • 1 November 2011.  The group heard about the impact of regional bowel cancer awareness campaigns and the plan to roll this work out nationally. They also assessed what actions they wanted to take in the light of the debate in Westminster Hall.
  • 12 October 2011. The group held a Westminster Hall debate on the urgent need for improving awareness of ovarian cancer, 14 MPs spoke in the debate and it resulted in a meeting between the APPG and the Minster for Cancer Services.
  • 12 July 2011. Annual General Meeting 2011
  • 17 May 2011. The subject for this meeting was NICE (National Institute for Health and Clinical Excellence) and the new Quality Standards.
  • 2 February 2011. This was a joint meeting of all the All Party Groups related to cancer, with a question and answer session with the Minister for Care Services .
  • 25 January 2011. The focus for this meeting was primary care and ovarian cancer. Speakers included representation from the Cancer Diagnostics Advisory Board, and Dr Sarah Wollaston, MP and member of the Health Select Committee. 


  • 27 October 2010: At the first meeting, the group  discussed issues around ovarian cancer with National Cancer Director, Professor Mike Richards. There was a particular focus on the 2010 health reforms and how they might impact on women who have the disease.
  • 29 June 2010The Six Simple Steps campaign was launched in Parliament at  a reception hosted by Sharon Hodgson MP on behalf of Target Ovarian Cancer. Enough support was received from MPs and Lords for Sharon to set up the All-Party Parliamentary Group on Ovarian Cancer.  

Read related news

World Ovarian Cancer Day
Wednesday 9 May 2018
For World Ovarian Cancer Day our Chief Executive Annwen Jones wrote an article for NHS England reflecting on the progress being made to tackle the disease and setting out the challenges going forward.  Today I am thinking of the 230,000 women diagnosed worldwide every year and their loved ones as...
Women taking over parliament
Friday 4 May 2018
It has been a busy few months for our ovarian cancer campaigners and staff who take action in the UK Parliament to improve health policy for women with ovarian cancer. MPs are looking deeper into early diagnosis The All-Party Parliamentary Group on Ovarian Cancer (APPG) is a group of MPs and peers...
Monday 13 July 2015
Today, the Scottish Medicines Consortium (SMC) has announced that it has rejected olaparib (Lynparza).   This decision comes after both the Cancer Drugs Fund and NICE rejected the drug on cost grounds in England and Wales. Olaparib was being assessed as a maintenance treatment of relapsed platinum-...
Friday 10 July 2015
The All Party Parliamentary Group (APPG) on Ovarian Cancer held their Annual General Meeting (AGM) on 10 June. Set up in 2011, the APPG has over 60 members and meets several times during the year. Target Ovarian Cancer provides secretariat duties for the group. The purpose of the APPG is to provide...